Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01983293 · ClinicalTrials.gov registry record · NA
CRT Implant Strategy Using the Longest Electrical Delay for Non-left Bundle Branch Block Patients
A NA study of Non-left Bundle Branch Block and Ischemic or Non-ischemic Cardiomyopathy, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 248
- Enrollment target
- 20
- Study locations
NCT01983293 is a NA study of Non-left Bundle Branch Block and Ischemic or Non-ischemic Cardiomyopathy that has completed, run by Abbott Medical Devices. The registered enrollment target is 248 participants. The trial reports 20 study locations across 10 states.
The verdict
NCT01983293, a NA study of Non-left Bundle Branch Block and Ischemic or Non-ischemic Cardiomyopathy, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 248 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to analyze the effect of left ventricular lead pacing location in the non-left bundle branch block (non-LBBB) heart failure patient population. The left ventricular lead pacing location will be guided by either the pacing site with the largest amount of dyssynchrony as measured by the LV electrical delay (QLV) or the physician's standard of care implant approach.
Conditions Studied
Interventions
- DEVICE QLV based implant strategy
- DEVICE Standard of care implant strategy
Study Locations (20)
California
- Glendale Adventist Medical Center - Glendale
- USC University Hospital - Los Angeles
- Mission Hospital - Mission Viejo
- St. Joseph's Medical Center - Stockton
Georgia
- Piedmont Heart Institute - Atlanta
- Emory University Hospital - Atlanta
- Atlanta Heart Associates - Riverdale - Riverdale
Michigan
- Henry Ford Hospital - Detroit
- St. John Hospital and Medical Center - Detroit
- McLaren Macomb - Mount Clemens
Florida
- Baker-Gilmour Cardiovascular Institute - Jacksonville
- Northside Hospital - St. Petersburg
Kentucky
- Central Baptist Hospital - Lexington
- University of Kentucky - Lexington
Massachusetts
- Tufts Medical Center - Boston
- Massachusetts General Hospital - Boston
Louisiana
- Oschner Medical Center - New Orleans
Maryland
- Johns Hopkins University Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2013-11 |
| Est. Completion | 2018-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01983293
The ClinicalTrials.gov registry entry for NCT01983293 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 248 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Non-left Bundle Branch Block appearing as the primary indexed condition, and to 2 interventions - of which QLV based implant strategy is the first listed.
NCT01983293 reports 20 study locations spanning 10 distinct geographic areas - top geographies include California, Georgia, Michigan.
Frequently Asked Questions
What is clinical trial NCT01983293 about?
NCT01983293 is a clinical study titled "CRT Implant Strategy Using the Longest Electrical Delay for Non-left Bundle Branch Block Patients". The purpose of this study is to analyze the effect of left ventricular lead pacing location in the non-left bundle branch block (non-LBBB) heart failure patient population. The left ventricular lead pacing location will be guided by either the pacing site with the largest amount of dyssynchrony as m...
What is the current status of trial NCT01983293?
This trial is currently completed. It is a NA study. The enrollment target is 248 participants. The study started on 2013-11. Estimated completion is 2018-01.
What conditions does trial NCT01983293 study?
This clinical trial studies the following conditions: Non-left Bundle Branch Block, Ischemic or Non-ischemic Cardiomyopathy.
What interventions are being tested in trial NCT01983293?
The interventions under investigation include: QLV based implant strategy (DEVICE), Standard of care implant strategy (DEVICE).
Who is sponsoring clinical trial NCT01983293?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01983293 being conducted?
This trial has 20 study locations across California, Florida, Georgia, Kentucky, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-left Bundle Branch Block
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Non-left Bundle Branch Block
All registered trials for this condition
Ischemic or Non-ischemic Cardiomyopathy
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.